Nina Shah

Nina Shah

Financials Analyst

Financials analyst covering banks, insurers, and specialty finance. Background in credit risk and ALM with experience stress-testing NIM, CET1, and loss provisions across macro cycles. Emphasizes underwriting quality, funding mix, regulatory constraints, and shareholder returns.

Articles 755

Jan 16, 2026 Finance

X Social Media Experiences Second Major Service Interruption in a Week

Service Interruptions Compound Challenges Amid Regulatory Scrutiny of X’s AI Features

Elon Musk's social media platform X encountered a significant service outage on Friday, its second widespread disruption in the span of a week. The pl...

CIA Chief Conducts Diplomatic Dialogue with Venezuela's Interim Leader
Jan 16, 2026 News & Politics

CIA Chief Conducts Diplomatic Dialogue with Venezuela's Interim Leader

John Ratcliffe's Caracas visit signals possible U.S.-Venezuela collaboration amid political shifts

CIA Director John Ratcliffe met with Venezuela's acting President Delcy Rodríguez in Caracas, marking a significant engagement between the United Sta...

Trump Set to Grant Clemency to Former Puerto Rican Governor Wanda Vázquez
Jan 16, 2026 News & Politics

Trump Set to Grant Clemency to Former Puerto Rican Governor Wanda Vázquez

The planned pardon comes amid controversy over a federal campaign finance conviction

President Donald Trump intends to pardon ex-Puerto Rico Governor Wanda Vázquez, who pleaded guilty to campaign finance violations in a case involving...

Jan 16, 2026 Finance

Delta Air Lines' Measured Outlook Highlights Strength Amid Economic Uncertainty

Analyst Views Emphasize Solid Cash Flow, Premium Demand, and Strategic Growth Despite Conservative Guidance

Delta Air Lines projects cautious earnings for 2026 due to macroeconomic unpredictability but demonstrates robust free cash flow, low leverage, and st...

Jan 16, 2026 Finance

State Street Closes 2025 With Unprecedented $5.7 Trillion in Assets Under Management

Strong Fourth Quarter Earnings and Solid Asset Growth Mark Year-End Performance

State Street Corporation reported impressive financial results for the fourth quarter and finalized 2025 with record-breaking assets under management....

Jan 16, 2026 Trade Ideas

Sarepta After Elevidys: Short on Safety, Long on Uncertainty

Why the market's reaction to Elevidys-related headwinds makes SRPT a tactical short (with guarded sizing)

Sarepta's Q3 2025 filing shows a sharp revenue deceleration, a large inventory build and recurring swings in profitability. Combined with mounting sha...

Trade Idea Short
Jan 16, 2026 Finance

ASML Surges Past $500 Billion Market Cap on AI Chip Investment Upsurge

Rising Capital Expenditure from TSMC Fuels Optimism Among Analysts for Semiconductor Equipment Leader

ASML Holding NV's stock recently reached a 52-week high, pushing its market valuation beyond the $500 billion threshold. This surge is driven by escal...

Jan 16, 2026 Finance

Invitation Homes Bolsters Southeast Build-to-Rent Presence with ResiBuilt Acquisition

Strategic move aims to enhance in-house development capacity amid strong rental single-family home demand

Invitation Homes Inc. has announced its acquisition of ResiBuilt Homes, LLC, a Southeast-focused developer, for $89 million plus performance-based inc...

Jan 16, 2026 Trade Ideas

Flowers Foods: Buy the Panic - Income-Rich Baker with a Cheap Price and Catalysts

Quarterly weakness has been punished hard; balance sheet, steady cash flow and an accretive acquisition make this a tactical buy.

Flowers Foods (FLO) has seen its shares fall roughly 40% from ~19 to ~11 over the last year despite stable operating cash flow, a reliable dividend an...

Trade Idea Long
FDA's Expedited Drug Review Initiative Sparks Internal Concerns and Legal Ambiguities
Jan 16, 2026 News & Politics

FDA's Expedited Drug Review Initiative Sparks Internal Concerns and Legal Ambiguities

Accelerated approval program under FDA commissioner raises questions over scientific oversight and legal authority

The FDA's new expedited drug approval program, designed to prioritize medicines aligning with U.S. national priorities, is generating significant unea...